KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) EPS (Weighted Average and Diluted) (2016 - 2025)

Merck (MRK) has disclosed EPS (Weighted Average and Diluted) for 17 consecutive years, with $1.2 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) fell 18.92% to $1.2 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.29 through Dec 2025, up 8.32% year-over-year, with the annual reading at $7.28 for FY2025, 8.01% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $1.2 at Merck, down from $2.32 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was $2.32 in Q3 2025, with the low at -$2.35 in Q2 2023.
  • Average EPS (Weighted Average and Diluted) over 5 years is $1.26, with a median of $1.52 recorded in 2024.
  • The sharpest move saw EPS (Weighted Average and Diluted) plummeted 251.61% in 2023, then skyrocketed 408.33% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at $1.78 in 2021, then tumbled by 33.71% to $1.18 in 2022, then plummeted by 140.68% to -$0.48 in 2023, then surged by 408.33% to $1.48 in 2024, then dropped by 18.92% to $1.2 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at $1.2, $2.32, and $1.76 for Q4 2025, Q3 2025, and Q2 2025 respectively.